KalVista Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule therapeutics for diseases with significant unmet needs, today announced the appointment of Bilal Arif as Chief Operating Officer (COO) and Linea Aspesi as Chief People Officer (CPO),…
Rahway, N.J. – Merck, known as MSD outside the United States and Canada, announced the initiation of three new Phase 2b clinical trials to evaluate the safety and efficacy of tulisokibart (MK-7240), an investigational humanized monoclonal antibody designed to target…
Owlstone Medical, the global leader in Breath Biopsy® technology for early disease detection and precision medicine, announced it has been awarded up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to advance the Platform Optimizing SynBio…
NanoPhoria Bioscience, a next-generation biotech company pioneering precision nanomedicine for cardiovascular and chronic diseases, today announced the first close of its €83.5 million Series A financing round. The round was co-led by XGEN Venture, Sofinnova Partners, and CDP Venture Capital,…
The University of Phoenix College of Doctoral Studies has unveiled a new white paper titled “Reinventing Productivity: Aligning AI Innovation with Human Potential in the Modern Workforce.” Authored by Jessica Sylvester, Ed.D., MBA, Senior Manager of College Operations, associate faculty…
BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, a strategic initiative led by CvilleBioHub to strengthen Virginia’s biotechnology ecosystem. The company’s headquarters relocation to CvilleBioHub’s state-of-the-art facilities at…
Alto Neuroscience, Inc., a clinical-stage biopharmaceutical company pioneering precision medicines for neuropsychiatric disorders, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ALTO-101 for the treatment of cognitive impairment associated with schizophrenia (CIAS). This…
Bruker Corporation today announced the receipt of multiple new orders for its advanced Nuclear Magnetic Resonance (NMR) instrumentation from three leading U.S. research institutions — the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University. Supported…
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) in combination with lurbinectedin (Zepzelca®) for the maintenance treatment of adults with extensive-stage small…
GoSaaS, Inc., a long-time Oracle Cloud Applications implementation partner, has announced a significant brand evolution — unveiling a new domain, GoSaaS.ai, and a refreshed logo to underscore its AI-first strategy. The rebrand marks an important step in the company’s journey…